Haleon PLC closed 5.20% below its 52-week high of £4.18, which the company achieved on March 4th.

Haleon PLC closed 2.61% below its 52-week high of £4.18, which the company reached on March 4th.

Her appointment reinforces the company’s commitment to advancing everyday health in one of the region’s most strategic growth ...

The campaign features a lineup of 18 films in nine regional languages. The films feature real-life consumer stories, ...

Pakistan’s pharmaceutical retail market reached Rs. 1.049 trillion in sales for the 12 months ending March 2025, reflecting a ...

Pavan Wani, Category Lead - Pain & Respiratory, Haleon ISC speaks on enduring success of its legacy brands, importance of ...

Consumer health giant Haleon has been given a thumbs-up from GenM, earning the menopause awareness company’s MTick ...

While a relatively recent phenomenon, its prevalence is increasing rapidly, with 85% or respondents in a survey saying they ...

Most readers would already be aware that Haleon's (LON:HLN) stock increased significantly by 13% over the past ...

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately reported by Alliance News: ...

Haleon on Thursday raised its medium-term target for profit growth from 2026, banking on strength in key markets and costs ...

Haleon on Thursday raised its medium-term target for profit growth from 2026, banking on strength in key markets and costs cuts within its supply chain, which would save the consumer healthcare group ...